Skip to Content

RINGERS SOLUTION FOR INFUSION

Active substance(s): CALCIUM CHLORIDE DIHYDRATE / POTASSIUM CHLORIDE / SODIUM CHLORIDE

View full screen / Print PDF » Download PDF ⇩
Transcript
PACKAGE LEAFLET: INFORMATION FOR THE USER
Ringer’s Solution for Infusion
$FWLYHVXEVWDQFHVVRGLXPFKORULGHSRWDVVLXPFKORULGHDQG
calcium chloride dihydrate
5LQJHUőV6ROXWLRQIRU,QIXVLRQLVXVHGWR
treat a loss of body water (dehydration) and
FKHPLFDOV HJE\KHDY\VZHDWLQJNLGQH\
disorders)

Read all of this leaflet carefully before you
are given this medicine because it contains
important information for you.
Ř .HHSWKLVOHDƃHW DJDLQ
Ř ,I\RXKDYHDQ\IXUWKHUTXHVWLRQVDVN\RXU
GRFWRURUQXUVH
Ř ,I\RXJHWDQ\VLGHHIIHFWVWDONWR\RXU
GRFWRURUQXUVH7KLVLQFOXGHVDQ\SRVVLEOH
VLGHHIIHFWVQRWOLVWHGLQWKLVOHDƃHW

2. What you need to know before
you are given Ringer’s Solution
for Infusion
Do NOT receive Ringer’s Solution for
Infusion if you are suffering from any
of the following conditions

What is in this leaflet:
 :KDW5LQJHUőV6ROXWLRQIRU,QIXVLRQLV
and what it is used for
 :KDW\RXQHHGWRNQRZEHIRUH\RXDUH
JLYHQ5LQJHUőV6ROXWLRQIRU,QIXVLRQ
 +RZ\RXZLOOEHJLYHQ5LQJHUőV6ROXWLRQ
for Infusion
 3RVVLEOHVLGHHIIHFWV
 +RZWRVWRUH5LQJHUőV6ROXWLRQIRU
Infusion
 &RQWHQWVRIWKHSDFNDQGRWKHU
information

Ř ZKHQWKHUHLVWRRPXFKƃXLGLQWKHVSDFHV
around the cells of the body (extracellular
hyperhydration)
Ř ZKHQWKHUHLVDODUJHUYROXPHRIEORRGLQ
WKHEORRGYHVVHOVWKDQWKHUHVKRXOGEH
K\SHUYRODHPLD
Ř VHYHUHNLGQH\IDLOXUH ZKHQ\RXUNLGQH\V
GRQRWZRUNZHOODQG\RXUHTXLUHGLDO\VLV 
Ř XQFRPSHQVDWHGKHDUWIDLOXUH7KLVLVKHDUW
IDLOXUHWKDWLVQRWDGHTXDWHO\WUHDWHGDQG
causes symptoms such as:
– shortness of breath
– swelling of the ankles
Ř ZKHQWKHUHLVWRRPXFKƃXLGLQWKHERG\
caused by too many salts in the blood
(hypertonic dehydration)
Ř KLJKHUOHYHOVRISRWDVVLXPLQWKHEORRG
than normal (hyperkalaemia)

1. What Ringer’s Solution for
Infusion is and what it is used for
5LQJHUőV6ROXWLRQIRU,QIXVLRQLVDVROXWLRQRI
the following substances in water:
Ř VRGLXPFKORULGH
Ř SRWDVVLXPFKORULGH
Ř FDOFLXPFKORULGHGLK\GUDWH

SA-30-01-797
1a

SA-30-01-797

Ř KLJKHUOHYHOVRIVRGLXPLQWKHEORRGWKDQ
normal (hypernatraemia)
Ř KLJKHUOHYHOVRIFDOFLXPLQWKHEORRGWKDQ
normal (hypercalcaemia)
Ř KLJKHUOHYHOVRIFKORULGHLQWKHEORRGWKDQ
normal (hyperchloraemia)
Ř VHYHUHKLJKEORRGSUHVVXUH K\SHUWHQVLRQ
Ř EXLOGXSRIƃXLGXQGHUWKHVNLQDIIHFWLQJ
all parts of the body (general oedema)
Ř OLYHUGLVHDVHWKDWFDXVHVƃXLGWREXLOGXS
within the abdomen (ascitic cirrhosis)
Ř LI\RXDUHWDNLQJFDUGLDFJO\FRVLGHV
(cardiotonics) used to treat heart failure,
VXFKDVGLJLWDOLVRUGLJR[LQ VHHDOVR
œ2WKHU0HGLFLQHVDQG5LQJHUőV6ROXWLRQIRU
Infusion”)

Ř DGUHQRFRUWLFDOLQVXIƂFLHQF\ WKLVGLVHDVH
of the adrenal gland affects hormones that
control the concentration of chemicals in
WKHERG\ 
Ř DORVVRIZDWHUIURPWKHERG\ DFXWH
GHK\GUDWLRQHJIURPYRPLWLQJRU
diarrhoea)
Ř H[WHQVLYHWLVVXHGDPDJH DVFDQRFFXULQ
VHYHUHEXUQV
Ř GLVHDVHVDVVRFLDWHGZLWKKLJKOHYHOVRI
YLWDPLQ' HJVDUFRLGRVLVDGLVHDVH
affecting the skin and internal organs)
:KHQ\RXDUHJLYHQWKLVLQIXVLRQ\RXU
doctor will take blood and urine samples and
monitor:
Ř WKHDPRXQWRIƃXLGLQ\RXUERG\
Ř \RXUYLWDOVLJQV
Ř WKHDPRXQWRIFKHPLFDOVVXFKDVVRGLXP
potassium, calcium and chlorides in your
blood (your plasma electrolytes)
$OWKRXJK5LQJHUőV6ROXWLRQIRU,QIXVLRQ
contains potassium and calcium, it does not
contain enough to:
Ř PDLQWDLQOHYHOVRIWKHVHFKHPLFDOV
Ř WUHDWYHU\ORZEORRGSODVPDOHYHOVRI
SRWDVVLXP VHYHUHSRWDVVLXPGHƂFLHQF\ 
RUFDOFLXP VHYHUHFDOFLXPGHƂFLHQF\ 
Once your dehydration has been treated using
5LQJHUőV6ROXWLRQIRU,QIXVLRQ\RXUGRFWRU
ZLOOJLYH\RXDGLIIHUHQWLQIXVLRQWRSURYLGH
\RXZLWKHQRXJKSRWDVVLXPDQGFDOFLXP
DUHUHFHLYLQJSDUHQWHUDOQXWULWLRQ QXWULWLRQ
JLYHQE\LQIXVLRQLQWRDYHLQ ,I\RXDUHJLYHQ
5LQJHUőV6ROXWLRQIRU,QIXVLRQIRUDORQJWLPH
\RXZLOOEHJLYHQDQH[WUDVRXUFHRIQXWULHQWV
Calcium chloride can be harmful if injected
LQWRWKHERG\WLVVXHV7KHUHIRUHWKH5LQJHUőV
6ROXWLRQIRU,QIXVLRQPXVWQRWEHJLYHQE\
injecting it into a muscle (intramuscular
LQMHFWLRQ $OVR\RXUGRFWRUZLOOPDNHHYHU\
HIIRUWWRDYRLGWKHHVFDSHRIWKHVROXWLRQLQWR
WKHWLVVXHVVXUURXQGLQJWKHYHLQ

Warnings and precautions
7DONWR\RXUGRFWRURUQXUVHLI\RXKDYH
RUKDYHKDGDQ\RIWKHIROORZLQJPHGLFDO
conditions:
Ř KHDUWIDLOXUH
Ř UHVSLUDWRU\IDLOXUH OXQJGLVHDVH  VSHFLDO
PRQLWRULQJPD\EHUHTXLUHGLQWKHDERYH
conditions)
Ř DQ\W\SHRIKHDUWGLVHDVHRULPSDLUHGKHDUW
function
Ř LPSDLUHGNLGQH\IXQFWLRQ
Ř KLJKEORRGSUHVVXUH K\SHUWHQVLRQ
Ř EXLOGXSRIƃXLGXQGHUWKHVNLQSDUWLFXODUO\
around the ankles (peripheral oedema)
Ř EXLOGXSRIƃXLGLQWKHOXQJV SXOPRQDU\
oedema)
Ř KLJKEORRGSUHVVXUHGXULQJSUHJQDQF\
(pre-eclampsia)
Ř DGLVHDVHWKDWFDXVHVKLJKOHYHOV
of a hormone called aldosterone
(aldosteronism)
Ř DQ\RWKHUFRQGLWLRQDVVRFLDWHGZLWK
sodium retention (when the body retains
too much sodium), such as treatment with
steroids (see also below “Other medicines
DQG5LQJHUőV6ROXWLRQIRU,QIXVLRQŔ 

SA-30-01-797
2a

Ř DQJLRWHQVLQ,,UHFHSWRUDQWDJRQLVWV XVHG
to treat high blood pressure)
Ř WDFUROLPXV XVHGWRSUHYHQWUHMHFWLRQRID
transplant and to treat some skin diseases)
Ř F\FORVSRULQ XVHGWRSUHYHQWUHMHFWLRQRID
transplant)
Other medicines that can affect or be affected
E\5LQJHUőV6ROXWLRQIRU,QIXVLRQLQFOXGH
Ř WKLD]LGHGLXUHWLFVVXFKDV
K\GURFKORURWKLD]LGHRUFKORUWDOLGRQH
Ř YLWDPLQ'

5LQJHUőV6ROXWLRQIRU,QIXVLRQPXVWQRWEH
JLYHQWKURXJKWKHVDPHQHHGOHDVDEORRG
WUDQVIXVLRQ7KLVFDQGDPDJHWKHUHGEORRG
FHOOVRUFDXVHWKHPWRFOXPSWRJHWKHU

Other medicines and Ringer’s
Solution for Infusion
7HOO\RXUGRFWRURUQXUVHLI\RXDUHWDNLQJRU
KDYHUHFHQWO\WDNHQDQ\RWKHUPHGLFLQHV
It is particularly important that you inform
your doctor if you are taking:
Ř FDUGLDFJO\FRVLGHV FDUGLRWRQLFV VXFK
as digitalis or digoxin, used to treat heart
failure as they must not be used with
5LQJHUőV6ROXWLRQIRU,QIXVLRQ VHHDOVR
VHFWLRQœ'RQRWUHFHLYH5LQJHUőV6ROXWLRQ
IRU,QIXVLRQLI\RXDUHVXIIHULQJIURPřŔ 
7KHHIIHFWVRIWKHVHGUXJVFDQEH
LQFUHDVHGE\FDOFLXP7KLVFDQOHDGWROLIH
threatening changes to the heart rhythm
Ř FRUWLFRVWHURLGV DQWLLQƃDPPDWRU\
medicines)
Ř FDUEHQR[RORQH DQDQWLLQƃDPPDWRU\
medicine used to treat stomach ulcers)
7KHVHPHGLFLQHVFDQFDXVHWKHERG\WR
accumulate sodium and water, leading to:
WLVVXHVZHOOLQJGXHWRƃXLGFROOHFWLRQXQGHU
the skin (oedema)
KLJKEORRGSUHVVXUH K\SHUWHQVLRQ 
7KHIROORZLQJPHGLFLQHVFDQLQFUHDVHWKH
FRQFHQWUDWLRQRISRWDVVLXPLQWKHEORRG
7KLVHIIHFWFDQEHOLIHWKUHDWHQLQJ$ULVHLQ
WKHEORRGSRWDVVLXPOHYHOVLVPRUHOLNHO\WR
RFFXULI\RXKDYHNLGQH\GLVHDVH
Ř SRWDVVLXPVSDULQJGLXUHWLFV FHUWDLQZDWHU
WDEOHWVHJDPLORULGHVSLURQRODFWRQH
triamterene) (Note that these medicines
may be included in combination medicinal
products)
Ř DQJLRWHQVLQFRQYHUWLQJHQ]\PH $&( 
inhibitors (used to treat high blood
pressure)

Ringer’s Solution for Infusion with
food and drink
FDQHDWRUGULQN

Pregnancy, breast-feeding and
fertility
If you are pregnant or breast-feeding, think
\RXPD\EHSUHJQDQWRUDUHSODQQLQJWRKDYH
DEDE\DVN\RXUGRFWRURUQXUVHIRUDGYLFH
EHIRUHWDNLQJWKLVPHGLFLQH
5LQJHUőV6ROXWLRQIRU,QIXVLRQFDQEHXVHG
VDIHO\GXULQJSUHJQDQF\RUEUHDVWIHHGLQJ
Calcium can reach your unborn baby through
the placenta and, after birth, through the
EUHDVWPLON OHYHOVRIFKHPLFDOVLQ\RXUEORRGDQGWKH
DPRXQWRIƃXLGLQ\RXUERG\
+RZHYHULIDQRWKHUPHGLFLQHLVWREHDGGHG
to your solution for infusion during pregnancy
or breast-feeding you should:
Ř FRQVXOW\RXUGRFWRU
Ř UHDGWKH3DFNDJH/HDƃHWRIWKHPHGLFLQH
WKDWLVWREHDGGHG

Driving and using machines
5LQJHUőV6ROXWLRQIRU,QIXVLRQGRHVQRWDIIHFW
\RXUDELOLW\WRGULYHRUXVHPDFKLQHV

SA-30-01-797
3a

Ř PXVFOHZHDNQHVV
Ř DQLQDELOLW\WRPRYH SDUDO\VLV
Ř DQLUUHJXODUKHDUWEHDW FDUGLDF
arrhythmias)
Ř KHDUWEORFN DYHU\VORZKHDUWEHDW
Ř FDUGLDFDUUHVW WKHKHDUWVWRSVEHDWLQJD
life-threatening situation)
Ř FRQIXVLRQ
Ř DGHFUHDVHGDSSHWLWH DQRUH[LD
Ř IHHOLQJVLFN QDXVHD
Ř YRPLWLQJ
Ř FRQVWLSDWLRQ
Ř DEGRPLQDOSDLQ
Ř PHQWDOGLVWXUEDQFHVVXFKDVLUULWDELOLW\RU
depression
Ř GULQNLQJORWVRIZDWHU SRO\GLSVLD
Ř SURGXFLQJPRUHXULQHWKDQQRUPDO
(polyuria)
Ř NLGQH\GLVHDVHGXHWREXLOGXSRIFDOFLXP
in the kidneys (nephrocalcinosis)
Ř NLGQH\VWRQHV
Ř FRPD XQFRQVFLRXVQHVV
Ř FKDON\WDVWH
Ř UHGQHVV KRWƃXVKHV
Ř GLODWDWLRQRIWKHEORRGYHVVHOVLQWKHVNLQ
SHULSKHUDOYDVRGLODWDWLRQ
Ř DFLGLƂFDWLRQRIWKHEORRG DFLGRVLV OHDGLQJ
to tiredness, confusion, lethargy and
increased breathing rate
,I\RXGHYHORSDQ\RIWKHVHV\PSWRPV\RX
PXVWLQIRUP\RXUGRFWRULPPHGLDWHO\ LQIXVLRQZLOOEHVWRSSHGDQG\RXZLOOEHJLYHQ
WUHDWPHQWGHSHQGLQJRQWKHV\PSWRPV
,IDPHGLFLQHKDVEHHQDGGHGWR\RXU5LQJHUőV
6ROXWLRQIRU,QIXVLRQEHIRUHRYHULQIXVLRQ
occurs, that medicine may also cause
V\PSWRPV /HDƃHWRIWKHDGGHGPHGLFLQHIRUDOLVWRI
SRVVLEOHV\PSWRPV

3. How to use Ringer’s Solution for
Infusion
5LQJHUőV6ROXWLRQIRU,QIXVLRQZLOOEHJLYHQ
WR\RXE\DGRFWRURUQXUVH decide on how much you need and when it
LVWREHJLYHQ7KLVZLOOGHSHQGRQ\RXUDJH
weight, and condition and the reason for
WUHDWPHQW7KHDPRXQW\RXDUHJLYHQPD\
also be affected by other treatments you are
UHFHLYLQJ
You should NOT be given Ringer’s Solution
for Infusion if there are particles floating in
the solution or if the pack is damaged in any
way.
5LQJHUőV6ROXWLRQIRU,QIXVLRQZLOOXVXDOO\EH
JLYHQWR\RXWKURXJKDSODVWLFWXEHDWWDFKHG
WRDQHHGOHLQDYHLQ8VXDOO\DYHLQLQ\RXU
DUPLVXVHGWRJLYH\RXWKHLQIXVLRQ+RZHYHU
\RXUGRFWRUPD\XVHDQRWKHUPHWKRGWRJLYH
\RXWKHPHGLFLQH
:KHQ\RXDUHJLYHQ5LQJHUőV6ROXWLRQIRU
Infusion, your doctor will perform blood tests
to monitor your:
Ř EORRGOHYHOVRIVRGLXPSRWDVVLXPFDOFLXP
and chloride
Ř \RXUƃXLGOHYHOV
$Q\XQXVHGVROXWLRQVKRXOGEHWKURZQDZD\
5LQJHUőV6ROXWLRQIRU,QIXVLRQIURPDEDJWKDW
KDVEHHQSDUWO\XVHG

If you receive more Ringer’s Solution
for Infusion than you should
,I\RXDUHJLYHQWRRPXFK5LQJHUőV6ROXWLRQ
IRU,QIXVLRQ RYHULQIXVLRQ RU\RXDUHJLYHQ
\RXULQIXVLRQWRRTXLFNO\WKLVPD\OHDGWRWKH
following symptoms:
Ř ZDWHUDQGRUVRGLXP VDOW RYHUORDGZLWK
EXLOGXSRIOLTXLGLQWKHWLVVXHV RHGHPD 
causing swelling
Ř SLQVDQGQHHGOHVLQWKHDUPVDQGOHJV
(paresthesia)

Stop receiving your Ringer’s Solution
for Infusion
\RXWKLVLQIXVLRQ
SA-30-01-797
4a

DGGHG of the added medicine for a list of possible
V\PSWRPV
If you get any side effects, talk to your doctor
RUQXUVH7KLVLQFOXGHVDQ\SRVVLEOHVLGH
HIIHFWVQRWOLVWHGLQWKLVOHDƃHW

,I\RXKDYHDQ\IXUWKHUTXHVWLRQVRQWKHXVH
RIWKLVPHGLFLQHDVN\RXUGRFWRURUQXUVH

4. Possible side effects
Like all medicines, this medicine can cause
VLGHHIIHFWVDOWKRXJKQRWHYHU\ERG\JHWV
WKHP
7KHVLGHHIIHFWVDUHOLVWHGDFFRUGLQJWRWKHLU
IUHTXHQFLHV
Very common (occurring in more than 1 of
HYHU\SDWLHQWV
Ř FKDQJHVLQWKHFRQFHQWUDWLRQVRIWKH
chemicals in the blood (electrolyte
disturbances)
,I\RXVXIIHUIURPKHDUWGLVHDVHRUƃXLGLQWKH
lungs (pulmonary oedema):
Ř WRRPXFKƃXLGLQWKHERG\ K\SHUK\GUDWLRQ
Ř KHDUWIDLOXUH

5. How to store Ringer’s Solution
for Infusion
.HHSWKLVPHGLFLQHRXWRIWKHVLJKWDQGUHDFK
RIFKLOGUHQ
7KLVPHGLFLQDOSURGXFWGRHVQRWUHTXLUHDQ\
VSHFLDOWHPSHUDWXUHVWRUDJHFRQGLWLRQV
'RQRWXVHWKLVPHGLFLQHDIWHUWKHH[SLU\GDWH
ZKLFKLVVWDWHGRQWKHEDJ7KHH[SLU\GDWH
UHIHUVWRWKHODVWGD\RIWKDWPRQWK
'RQRWXVHWKLVPHGLFLQHLI\RXQRWLFH
SDUWLFOHVƃRDWLQJLQWKHVROXWLRQRULIWKHXQLW
LVGDPDJHGLQDQ\ZD\

Other
Ř UHDFWLRQVGXHWRWKHDGPLQLVWUDWLRQ
WHFKQLTXH
Ř IHYHU IHEULOHUHVSRQVH
Ř LQIHFWLRQDWWKHVLWHRILQIXVLRQ
Ř ORFDOSDLQRUUHDFWLRQ UHGQHVVRUVZHOOLQJ
at the site of infusion)
Ř LUULWDWLRQDQGLQƃDPPDWLRQRIWKHYHLQLQWR
ZKLFKWKHVROXWLRQLVLQIXVHG SKOHELWLV 
7KLVFDQFDXVHUHGQHVVSDLQRUEXUQLQJ
DQGVZHOOLQJDORQJWKHSDWKRIWKHYHLQLQWR
ZKLFKWKHVROXWLRQLVLQIXVHG
Ř WKHIRUPDWLRQRIDEORRGFORW YHQRXV
thrombosis) at the site of infusion, which
causes pain, swelling or redness in the
area of the clot
Ř HVFDSHRIWKHLQIXVLRQVROXWLRQLQWRWKH
WLVVXHVDURXQGWKHYHLQ H[WUDYDVDWLRQ 
7KLVFDQGDPDJHWKHWLVVXHVDQGFDXVH
VFDUULQJ
If a medicine has been added to the solution
for infusion, the added medicine may also
FDXVHVLGHHIIHFWV7KHVHVLGHHIIHFWVZLOO
depend on the medicine that has been

6. Contents of the pack and other
information
What Ringer’s Solution for Infusion
contains
7KHDFWLYHVXEVWDQFHVDUH
Ř VRGLXPFKORULGHJSHUOLWUH
Ř SRWDVVLXPFKORULGHJSHUOLWUH
Ř FDOFLXPFKORULGHGLK\GUDWHJSHUOLWUH
7KHRWKHULQJUHGLHQWVDUH
Ř ZDWHUIRULQMHFWLRQV
Ř VRGLXPK\GUR[LGH

What Ringer’s Solution for Infusion
looks like and contents of the pack
5LQJHUőV6ROXWLRQIRU,QIXVLRQLVDFOHDU
VROXWLRQIUHHIURPYLVLEOHSDUWLFOHV
,WLVVXSSOLHGLQDSRO\ROHƂQSRO\DPLGHSODVWLF
EDJV 9LDƃR (DFKEDJLVZUDSSHGLQD
VHDOHGSURWHFWLYHRXWHUSODVWLFRYHUSRXFK

SA-30-01-797
5a

7KHEDJVL]HVDUH
Ř PO
Ř PO
7KHEDJVDUHVXSSOLHGLQFDUWRQV(DFKFDUWRQ
FRQWDLQVRQHRIWKHIROORZLQJTXDQWLWLHV
Ř EDJVRIPO
Ř EDJVRIPO
1RWDOOSDFNVL]HVPD\EHPDUNHWHG

Marketing Authorisation Holder and
Manufacturers
Marketing Authorisation Holder:
7REHFRPSOHWHQDWLRQDOO\
Manufacturers:
Baxter SA
%RXOHYDUG5HQ«%UDQTXDUW
/HVVLQHV
Belgium
Baxter Healthcare Ltd.
&D[WRQ:D\
7KHWIRUG1RUIRON,36(
8QLWHG.LQJGRP
Bieffe Medital S.A.
&WUDGH%LHVFDV6HQHJ¾«
6DEL³£QLJR +XHVFD
Spain
This leaflet was last revised in October 2012

%D[WHUDQG9LDƃRDUHWUDGHPDUNVRI
%D[WHU,QWHUQDWLRQDOOQF

SA-30-01-797
6a

F

SA-30-01-797

Ringer’s Solution for Infusion
PDQGDWRU\6ROXWLRQVFRQWDLQLQJDGGLWLYHV
VKRXOGEHXVHGLPPHGLDWHO\DQGQRWVWRUHG
Adding medication or using an incorrect
DGPLQLVWUDWLRQWHFKQLTXHPLJKWFDXVHWKH
DSSHDUDQFHRIIHYHUUHDFWLRQVGXHWRWKH
SRVVLEOHLQWURGXFWLRQRIS\URJHQV,QFDVHRI
DGYHUVHUHDFWLRQLQIXVLRQPXVWEHVWRSSHG
LPPHGLDWHO\
'LVFDUGDIWHUVLQJOHXVH
'LVFDUGDQ\XQXVHGSRUWLRQ
'RQRWUHFRQQHFWSDUWLDOO\XVHGEDJV

The following information
is intended for healthcare
professionals only:
Handling and Preparation
8VHRQO\LIWKHVROXWLRQLVFOHDUZLWKRXWYLVLEOH
SDUWLFOHVDQGLIWKHFRQWDLQHULVXQGDPDJHG
Administer immediately following the
LQVHUWLRQRILQIXVLRQVHW
'RQRWUHPRYHXQLWIURPRYHUZUDSXQWLOUHDG\
IRUXVH
7KHLQQHUEDJPDLQWDLQVWKHVWHULOLW\RIWKH
SURGXFW
'RQRWXVHSODVWLFFRQWDLQHUVLQVHULHV
FRQQHFWLRQV6XFKXVHFRXOGUHVXOWLQDLU
embolism due to residual air being drawn
from the primary container before the
DGPLQLVWUDWLRQRIWKHƃXLGIURPWKHVHFRQGDU\
FRQWDLQHULVFRPSOHWHG3UHVVXUL]LQJ
LQWUDYHQRXVVROXWLRQVFRQWDLQHGLQƃH[LEOH
SODVWLFFRQWDLQHUVWRLQFUHDVHƃRZUDWHVFDQ
result in air embolism if the residual air in
WKHFRQWDLQHULVQRWIXOO\HYDFXDWHGSULRUWR
DGPLQLVWUDWLRQ8VHRIDYHQWHGLQWUDYHQRXV
DGPLQLVWUDWLRQVHWZLWKWKHYHQWLQWKHRSHQ
SRVLWLRQFRXOGUHVXOWLQDLUHPEROLVP9HQWHG
LQWUDYHQRXVDGPLQLVWUDWLRQVHWVZLWKWKHYHQW
in the open position should not be used with
ƃH[LEOHSODVWLFFRQWDLQHUV
7KHVROXWLRQVKRXOGEHDGPLQLVWHUHGZLWK
VWHULOHHTXLSPHQWXVLQJDQDVHSWLFWHFKQLTXH
7KHHTXLSPHQWVKRXOGEHSULPHGZLWKWKH
VROXWLRQLQRUGHUWRSUHYHQWDLUHQWHULQJWKH
V\VWHP
$GGLWLYHVPD\EHLQWURGXFHGEHIRUHLQIXVLRQ
or during infusion through the re-sealable
PHGLFDWLRQSRUW
:KHQDGGLWLYHLVXVHGYHULI\LVRWRQLFLW\
SULRUWRSDUHQWHUDODGPLQLVWUDWLRQ7KRURXJK
DQGFDUHIXODVHSWLFPL[LQJRIDQ\DGGLWLYHLV

1. Opening
D 5HPRYHWKH9LDƃRFRQWDLQHUIURPWKH
RYHUSRXFKMXVWEHIRUHXVH
E &KHFNIRUPLQXWHOHDNVE\VTXHH]LQJLQQHU
EDJƂUPO\,IOHDNVDUHIRXQGGLVFDUG
VROXWLRQDVVWHULOLW\PD\EHLPSDLUHG
F &KHFNWKHVROXWLRQIRUOLPSLGLW\DQG
DEVHQFHRIIRUHLJQPDWWHUV,IVROXWLRQ
is not clear or contains foreign matters,
GLVFDUGWKHVROXWLRQ

2. Preparation for administration
8VHVWHULOHPDWHULDOIRUSUHSDUDWLRQDQG
DGPLQLVWUDWLRQ
D 6XVSHQGFRQWDLQHUIURPH\HOHWVXSSRUW
E 5HPRYHSODVWLFSURWHFWRUIURPRXWOHWSRUW
at bottom of container:
– grip the small wing on the neck of the
port with one hand,
– grip the large wing on the cap with the
other hand and twist,
Ŏ WKHFDSZLOOSRSRII
F 8VHDQDVHSWLFPHWKRGWRVHWXSWKH
LQIXVLRQ
G $WWDFKDGPLQLVWUDWLRQVHW5HIHUWR
complete directions accompanying set
for connection, priming of the set and
DGPLQLVWUDWLRQRIWKHVROXWLRQ
SA-30-01-797
1b

3. Techniques for injection of
additive medications

5. Incompatibilities of additive
medications

Warning: Additives may be incompatible
(see paragraph 5 “Incompatibilities of additive
medications” below).
To add medication before administration
D 'LVLQIHFWPHGLFDWLRQSRUW
E 8VLQJV\ULQJHZLWKJDXJH PP 
WRJDXJH PP QHHGOHSXQFWXUH
UHVHDODEOHPHGLFDWLRQSRUWDQGLQMHFW
F 0L[VROXWLRQDQGPHGLFDWLRQWKRURXJKO\
For high-density medication such as
potassium chloride, tap the ports gently
ZKLOHSRUWVDUHXSULJKWDQGPL[
&DXWLRQ'RQRWVWRUHEDJVFRQWDLQLQJDGGHG
PHGLFDWLRQV
To add medication during administration
D &ORVHFODPSRQWKHVHW
E 'LVLQIHFWPHGLFDWLRQSRUW
F 8VLQJV\ULQJHZLWKJDXJH PP 
WRJDXJH PP QHHGOHSXQFWXUH
UHVHDODEOHPHGLFDWLRQSRUWDQGLQMHFW
G 5HPRYHFRQWDLQHUIURP,9SROHDQGRUWXUQ
WRDQXSULJKWSRVLWLRQ
H (YDFXDWHERWKSRUWVE\WDSSLQJJHQWO\
while the container is in an upright
SRVLWLRQ
I 0L[VROXWLRQDQGPHGLFDWLRQWKRURXJKO\
J 5HWXUQFRQWDLQHUWRLQXVHSRVLWLRQ
re-open the clamp and continue
administration

As with all parenteral solutions, before adding
PHGLFDWLRQVFRPSDWLELOLW\RIWKHVHDGGLWLYHV
ZLWKWKHVROXWLRQLQ9LDƃRFRQWDLQHUPXVWEH
DVVHVVHG
It is the responsibility of the physician to
MXGJHWKHLQFRPSDWLELOLW\RIDQDGGLWLYH
PHGLFDWLRQZLWKWKH5LQJHUőV6ROXWLRQIRU
,QIXVLRQE\FKHFNLQJIRUHYHQWXDOFRORXU
FKDQJHDQGRUHYHQWXDODSSHDUDQFHRI
SUHFLSLWDWHLQVROXEOHFRPSOH[HVRUFU\VWDOV
7KH,QVWUXFWLRQVIRU8VHRIWKHPHGLFLQDO
SURGXFWWREHDGGHGPXVWEHFRQVXOWHG
%HIRUHDGGLQJDGUXJYHULI\LWLVVROXEOHDQG
VWDEOHLQZDWHUDWWKHS+RI5LQJHUőV6ROXWLRQ
IRU,QIXVLRQ S+WR 
&DOFLXPVDOWVKDYHEHHQUHSRUWHGWREH
LQFRPSDWLEOHZLWKDZLGHUDQJHRIGUXJV
Complexes may form resulting in the
IRUPDWLRQRIDSUHFLSLWDWH
As a guidance, the following medications are
LQFRPSDWLEOHZLWKWKH5LQJHUőV6ROXWLRQ QRQ
H[KDXVWLYHOLVWLQJ 
Ř $PSKRWHULFLQ%
Ř &RUWLVRQH
Ř (U\WKURP\FLQODFWRELRQDWH
Ř (WDPLYDQ
Ř (WK\ODOFRKRO
Ř 7KLRSHQWDOVRGLXP
Ř 'LVRGLXPHGHWDWH
7KRVHDGGLWLYHVNQRZQWREHLQFRPSDWLEOH
VKRXOGQRWEHXVHG

4. In-use shelf life (Additives)
7KHFKHPLFDODQGSK\VLFDOVWDELOLW\RIDQ\
DGGLWLYHDWWKHS+RIWKH5LQJHUőVVROXWLRQLQ
WKH9LDƃRFRQWDLQHUVKRXOGEHHVWDEOLVKHG
SULRUWRXVH
)URPDPLFURELRORJLFDOSRLQWRIYLHZWKH
SURGXFWVKRXOGEHXVHGLPPHGLDWHO\,IQRW
used immediately, in-use storage times and
conditions prior to use are the responsibility
of the user and would normally not be
ORQJHUWKDQKRXUVDWWRr&XQOHVV
reconstitution has taken place in controlled
DQGYDOLGDWHGDVHSWLFFRQGLWLRQV

%D[WHUDQG9LDƃRDUHWUDGHPDUNVRI
%D[WHU,QWHUQDWLRQDOOQF

F

SA-30-01-797
2b

Expand view ⇕

Source: Medicines and Healthcare Products Regulatory Agency

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide